Education
About Us
Working with TipRanks
Follow Us
Andreas Eberhorn Insider Profile
4 Followers
Andreas Eberhorn, Chief Marketing Officer at Dermapharm Holding SE, holds ― shares in Dermapharm Holding SE (Ticker: DE:DMP). Most recently, Andreas Eberhorn Bought €1,492 shares of Dermapharm Holding SE on Jun 24, 2025 for an estimated value of 49.98K.
Andreas Eberhorn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Andreas Eberhorn does not currently own shares as a corporate insider.
A breakdown of Andreas Eberhorn's holdings
Insider Roles
Chief Marketing Officer
Roles that Andreas Eberhorn holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Andreas Eberhorn
Andreas Eberhorn's Trading History
List of latest transactions for each holding click on a transaction to see Andreas Eberhorn's performance on stock
You May Also Like
Andreas Eberhorn insider profile FAQ
What is the percentage of profitable transactions made by Andreas Eberhorn?
The percentage of profitable transactions made by Andreas Eberhorn is ―.
What is the average return per transaction made by Andreas Eberhorn?
The average return per transaction made by Andreas Eberhorn is ―.
What stocks does Andreas Eberhorn hold?
Andreas Eberhorn holds: DE:DMP stocks.
What was Andreas Eberhorn’s latest transaction?
Andreas Eberhorn latest transaction was an Informative Buy of €49.98K.
What was Andreas Eberhorn's most profitable transaction?
Andreas Eberhorn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Andreas Eberhorn's role in Dermapharm Holding SE?
Andreas Eberhorn's role in Dermapharm Holding SE is Chief Marketing Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.